OOIR: Observatory of International Research

Papers

(The TQCC of Nature Reviews Urology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Sexual recovery interventions following prostate cancer treatment	179
Novel intravesical gemcitabine delivery system (TAR-200) for neoadjuvant treatment of MIBC: context is everything	160
Texture analysis for patient selection	138
Single-cell and spatial sequencing of kidney cancer	115
Exploratory results from the CheckMate 214 trial	95
Human-relevant urothelial model provides insight into infection strategies and host response	75
Krause corpuscles act as genital vibration detectors	64
Immune infiltration associated with outcomes	63
Semen quality recovery following COVID-19	62
PARP inhibitors plus enzalutamide to treat mCRPC	62
Time for women-centred gynaecology	61
Top, bottom or vers? Creating a more equitable health system for sexual and gender minority patients with prostate cancer	60
Urine microbiota differ in bladder cancer	60
Advancing the state of the art in congenital obstructive uropathy	56
High-dose chemotherapy for relapsed testicular germ cell tumours	56
Considering urology in a planetary context	55
Preclinical models of bladder cancer: BBN and beyond	54
Implementation of patient-reported outcome measures into health care for men with localized prostate cancer	50
A clinical guide to rare male sexual disorders	49
FOXA2–KIT-driven lineage plasticity in NEPC	49
Proteomic-based analysis of testicular interstitial fluid	49
Prevalence of gender dysphoria in Japan	48
A new text message-based platform for self-management of patients with IC/BPS	47
Overcoming antibiotic resistance in complicated UTI	45
The evolving landscape of monogenic nephrolithiasis and therapeutic innovations	45

Promise without practice — charting the path forward for bladder cancer biomarkers	43
Madrid plays host to a celebration of urology	42
Microfluidic sperm selection	41
What happens in Vegas … shapes the future of urology	41
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers	41
Reducing the stigma of academic mental health can save lives	39
Is SARS-CoV-2-induced testicular damage in hamsters relevant?	39
Galectins as potential therapeutic targets in STIs in the female genital tract	39
Metaverse in surgery — origins and future potential	37
Antibiotic therapy for treating overactive bladder is not supported by clinical evidence	36
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer	36
Evolution of the World Health Organization semen analysis manual: where are we?	36
Bioinformatics in urology — molecular characterization of pathophysiology and response to treatment	34
A non-invasive assay for UTUC diagnosis	34
Pembrolizumab + axitinib beyond first-line therapy for mRCC	34
Vaccination to prevent untreatable gonorrhoea	34
Resolving the puzzle of same-sex sexual interactions	34
COVID can’t kill CopMich collaboration	34
Quest for a genetic biomarker for sickle cell disease priapism: rationale, progress and implications	33
Pain management in percutaneous nephrolithotomy — an approach rooted in pathophysiology	33
Personalized 3D models for prostate cancer surgery	32
Efficacy of the Revi system in treating urgency urinary incontinence	32
PEACEing together prostate cancer therapy	31
Measuring and improving the cradle-to-grave environmental performance of urological procedures	30
Sexual orientation, gender identity and COVID: a complicated picture	30
Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway	30
The mechanism of action of neuromodulation in the treatment of overactive bladder	30
Author Correction: Can PROMs improve racial equity in outcomes after prostatectomy?	30
Is it time to rethink the current patient-reported outcome measures?	28
Effect of high glucose on E. coli	27
Rucaparib improves PFS in patients with BRCA1/2-altered mCRPC	27
Secondary kidney stones — remove or leave?	26
The magic of MagSToNE	26
Cribriform morphology affects mpMRI imaging	26
A distinct TAM subset mediates immunotherapy resistance in prostate cancer	25
Women in urology: the past	25
Promising efficacy of UTI vaccines as an alternative to antibiotics	24
Successful mentorship for women in urology — a new era	24
Microultrasonography-guided prostate cancer biopsy	24
AUA returns to its former glory in Chicago	24
Robots learning to imitate surgeons — challenges and possibilities	23
Prostate cancer in transgender women — challenges in research and clinical care	23
Videourodynamics — role, benefits and optimal practice	23
Excluding PLND in favourable intermediate-risk prostate cancer: a PSMA-PET-directed perspective	22
The placebo and nocebo effects in functional urology	22
Current and emerging strategies to curb antibiotic-resistant urinary tract infections	22
Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer	21
Centralization of care for rare genetic syndromes associated with cancer: improving outcomes and advancing research on VHL disease	20
Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards	20
A clinical overview of people living with HIV and genitourinary cancer care	18

Metabolic response to immunotherapy in prostate cancer	17
Androgen receptor pathway inhibitor combination in prostate cancer	17
Going in circles: circMGA–HNRNPL feedback loop in bladder cancer	17
Detecting lymph node metastases for personalized radiotherapy in patients with prostate cancer	16
Management and cost of stent encrustation in pregnancy	16
Turning up the heat: CTLA4 blockade in urothelial cancer	15
Pride, not prejudice	15
AI for antibiotic design	15
Overall survival with adjuvant pembrolizumab in renal cell carcinoma — the shock of the lightning	15
Immune-based therapies in penile cancer	15
Evolving language reflects evolving understanding: updated terms for anatomical description in i/VSC/DSD	15
Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective	14
The future of patient-derived xenografts in prostate cancer research	13
The prognostic role of stroma in UTUC	13
De-clear cell differentiated renal cell carcinoma — a new therapeutic target	13
The evolving treatment landscape of metastatic urothelial cancer	13
Uncovering a link between COVID-19 and renal cell carcinoma	12
Improved phenotypic classification of male infertility to promote discovery of genetic causes	12
The value of women urologists — individual and institutional imperatives to address salary equity	12
Turning back time in the testes	12
We all get erections — de-gendering sexual arousal dysfunction in the ICD	12
Current and future pharmacotherapy for female sexual dysfunction	11
Vitamins as regulators of calcium-containing kidney stones — new perspectives on the role of the gut microbiome	11
Pelvic-fascia-sparing techniques and outcomes with RARP	11
The shifting treatment paradigm of metastatic renal cell carcinoma	11
New evidence and novel techniques for assessing intraoperative margins during radical prostatectomy	11
Breaking the silence: normalizing receptive anal intercourse for patients, for people and for myself	11
Power up to investigate PrEP	10
CMA mediates resistance to androgen inhibitors in prostate cancer	10
Effects of COVID-19 vaccine on semen parameters	10
Patient selection is key in IMbassador250	10
Hallmark discoveries in the biology of Wilms tumour	10
Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer	10
Tuft cells in prostate cancer	10
Men hold the balance of power	10
BAUSing back in Birmingham	10
The unclear role of PET–CT in localized radiorecurrent prostate cancer	10
Metabolism, mitochondria and metastasis in kidney cancer	9
Diagnosis of ccRCC	9
Mellow yellow: BilR reduces bilirubin to urobilinogen	9
ARNEO: neoadjuvant degarelix + apalutamide before surgery for high-risk prostate cancer	9
Spatiotemporal trends in human semen quality	8
Microbiota manipulation to prevent oxalate kidney stone formation	8
Male infertility and somatic health — insights into lipid damage as a mechanistic link	8
Mechanisms of the intestinal and urinary microbiome in kidney stone disease	8
A prompt-based stewardship to reduce extended-spectrum antibiotic treatment in UTI	8
Mechanisms of the Supra-T paradox	7
The ins and outs of penile erection	7
Testosterone replacement therapy and spermatogenesis in reproductive age men	7
Stepping up to prevent bacterial vaginosis recurrence	7
MRI diagnosis and radical prostatectomy outcomes	7
Pronouns in English: a user’s guide	7
Chlorination by-products in drinking water — association with bladder cancer risk	7
Pathophysiology and potential multimodal therapeutic strategies for IC/BPS	7
Genetic ancestry and racial differences in prostate tumours	7
Semen parameters across testicular cancer stages	7
Advances in sliding clip renorrhaphy for partial nephrectomy	7
Sperm activity affected by endometriosis	6
A great gathering at the 4th Clinical and Scientific Advances in UTI conference	6
Urology on a changing planet: links between climate change and urological disease	6
Artificial intelligence in the management of prostate cancer	6
Visual clues — dermatological manifestations of sexually transmitted infections in men	6
Prostate luminal progenitor cells: from mouse to human, from health to disease	6
Von Hippel–Lindau protein signalling in clear cell renal cell carcinoma	6
Feasibility and potential of an MRI-based prostate cancer screening	6
Genetic and biological drivers of prostate cancer disparities in Black men	6
Toilet-based continuous health monitoring using urine	6
Particulate matter leaves a bitter taste in testes	6
Syphilis on the rise — a need for alternative therapies and vaccines	6
Influence of substance use on male reproductive health and offspring outcomes	6
Clinical trial design for non-muscle-invasive bladder cancer	6